Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 6
1982 47
1983 90
1984 146
1985 265
1986 334
1987 425
1988 495
1989 669
1990 623
1991 667
1992 645
1993 687
1994 643
1995 665
1996 583
1997 647
1998 748
1999 896
2000 1043
2001 1361
2002 1590
2003 1871
2004 2170
2005 2761
2006 3168
2007 3763
2008 4328
2009 5008
2010 5599
2011 6084
2012 6547
2013 6895
2014 7424
2015 7542
2016 7808
2017 8294
2018 8598
2019 9118
2020 10009
2021 9515
2022 7978
2023 7083
2024 9515
2025 5328
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140,184 results

Results by year

Filters applied: . Clear all
Page 1
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.
Menter A, Strober BE, Kaplan DH, Kivelevitch D, Prater EF, Stoff B, Armstrong AW, Connor C, Cordoro KM, Davis DMR, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kavanaugh A, Kiselica M, Korman NJ, Kroshinsky D, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Paller AS, Parra SL, Pathy AL, Rupani RN, Siegel M, Wong EB, Wu JJ, Hariharan V, Elmets CA. Menter A, et al. J Am Acad Dermatol. 2019 Apr;80(4):1029-1072. doi: 10.1016/j.jaad.2018.11.057. Epub 2019 Feb 13. J Am Acad Dermatol. 2019. PMID: 30772098 Review.
Therapeutic monoclonal antibodies.
Breedveld FC. Breedveld FC. Lancet. 2000 Feb 26;355(9205):735-40. doi: 10.1016/s0140-6736(00)01034-5. Lancet. 2000. PMID: 10703815 Review.
Switching Biological Therapies in Severe Asthma.
Scioscia G, Nolasco S, Campisi R, Quarato CMI, Caruso C, Pelaia C, Portacci A, Crimi C. Scioscia G, et al. Int J Mol Sci. 2023 May 31;24(11):9563. doi: 10.3390/ijms24119563. Int J Mol Sci. 2023. PMID: 37298514 Free PMC article. Review.
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D'Haens G, Ferrante M, Schreiber S, Atreya R, Danese S, Lindsay JO, Bossuyt P, Siegmund B, Irving PM, Panaccione R, Cao Q, Neimark E, Wallace K, Anschutz T, Kligys K, Duan WR, Pivorunas V, Huang X, Berg S, Shu L, Dubinsky M; SEQUENCE Study Group. Peyrin-Biroulet L, et al. N Engl J Med. 2024 Jul 18;391(3):213-223. doi: 10.1056/NEJMoa2314585. N Engl J Med. 2024. PMID: 39018531 Clinical Trial.
FcRn Inhibitor Therapies in Neurologic Diseases.
Alfaidi N, Karmastaji S, Matic A, Bril V. Alfaidi N, et al. CNS Drugs. 2024 Jun;38(6):425-441. doi: 10.1007/s40263-024-01090-3. Epub 2024 May 9. CNS Drugs. 2024. PMID: 38724842 Review.
Newer Therapies in Rheumatology.
Bays A, Gardner GC. Bays A, et al. Med Clin North Am. 2024 Sep;108(5):829-842. doi: 10.1016/j.mcna.2024.02.004. Epub 2024 Apr 8. Med Clin North Am. 2024. PMID: 39084836 Review.
Dupilumab's duplicity.
Heymann WR. Heymann WR. J Am Acad Dermatol. 2024 Aug;91(2):249-250. doi: 10.1016/j.jaad.2024.05.041. Epub 2024 May 23. J Am Acad Dermatol. 2024. PMID: 38789044 No abstract available.
140,184 results
You have reached the last available page of results. Please see the User Guide for more information.